The hypothalamus, brain-catecholamines, and drug therapy for gigantism and acromegaly.
D000172:Acromegaly / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism*; D002746:Chlorpromazine / Q000494:pharmacology / Q000627:therapeutic use; D004298:Dopamine / Q000502:physiology; D018492:Dopamine Antagonists; D005877:Gigantism / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism*; D008525:Medroxyprogesterone / Q000494:pharmacology / Q000627:therapeutic use; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000502:physiology
D002395:Catecholamines; D018492:Dopamine Antagonists; D013006:Growth Hormone; D008525:Medroxyprogesterone; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine